Evidence map›Paper›PMID 22528482›Full record

Trial reportThe Journal of biological chemistry2012

Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade.

Marcin Okroj, Emelie Holmquist, Jonatan Sjölander, Leticia Corrales, Tore Saxne, Hans-Georg Wisniewski, Anna M Blom

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Defining the versican interactome in lung health and disease.American journal of physiology. Cell physiology · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Hyaluronan interactions with innate immunity in lung biology.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Alterations in inter-alpha inhibitor protein expression after hypoxic-ischemic brain injury in neonatal rats.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marcin OkrojDepartment of Laboratory Medicine, Lund University, 20502 Malmö, Sweden.
Emelie Holmquist
Jonatan Sjölander
Leticia Corrales
Tore Saxne
Hans-Georg Wisniewski
Anna M Blom
Lund University · SENew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inter alpha inhibitor (IαI) is an abundant serum protein consisting of three polypeptides: two heavy chains (HC1 and HC2) and bikunin, a broad-specificity Kunitz-type proteinase inhibitor. The complex is covalently held together by chondroitin sulfate but during inflammation IαI may interact with TNF-stimulated gene 6 protein (TSG-6), which supports transesterification of heavy chains to hyaluronan. Recently, IαI was shown to inhibit mouse complement in vivo and to protect from complement-mediated lung injury but the mechanism of such activity was not elucidated. Using human serum depleted from IαI, we found that IαI is not an essential human complement inhibitor as was reported for mice and that such serum has unaltered hemolytic activity. However, purified human IαI inhibited classical, lectin and alternative complement pathways in vitro when added in excess to human serum. The inhibitory activity was dependent on heavy chains but not bikunin and detected at the level of initiating molecules (MBL, properdin) in the lectin/alternative pathways or C4b in the classical pathway. Furthermore, IαI affected formation and assembly of the C1 complex and prevented assembly of the classical pathway C3-convertase. Presence and putative interactions with TSG-6 did not affect the ability of IαI to inhibit complement thus implicating IαI as a potentially important complement inhibitor once enriched onto hyaluronan moieties in the course of local inflammatory processes. In support of this, we found a correlation between IαI/HC-containing proteins and hemolytic activity of synovial fluid from patients suffering from rheumatoid arthritis.

Indexed as

Complement ActivationAlpha-GlobulinsAnimalsArthritis, RheumatoidCell Adhesion MoleculesChondroitin SulfatesComplement System ProteinsFemaleHumansHyaluronic AcidLung InjuryMaleMiceSynovial FluidAlpha-GlobulinsCell Adhesion MoleculesChondroitin SulfatesComplement System ProteinsHyaluronic Acidinter-alpha-inhibitorTNFAIP6 protein, humanTnfaip6 protein, mouse

Identifiers

PMID22528482
PMCPMC3370193
OpenAlexW2139451321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.